IRF1 and neoplasm: Specifically, IFN-γ activates the JAK/STAT1/interferon regulatory factor 1 (IRF1) signaling pathway to upregulate ACSL4 transcription in tumor cells by promoting IRF1 binding to ACSL4 promoter region IFN-stimulated response elements.